APA (7th ed.) Citation

Böhm, M., Baumhäkel, M., Teo, K., Sleight, P., Probstfield, J., Gao, P., . . . Yusuf, S. (2010). Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation (New York, N.Y.), 121(12), 1439. https://doi.org/10.1161/CIRCULATIONAHA.109.864199

Chicago Style (17th ed.) Citation

Böhm, Michael, et al. "Erectile Dysfunction Predicts Cardiovascular Events in High-risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) Trials." Circulation (New York, N.Y.) 121, no. 12 (2010): 1439. https://doi.org/10.1161/CIRCULATIONAHA.109.864199.

MLA (9th ed.) Citation

Böhm, Michael, et al. "Erectile Dysfunction Predicts Cardiovascular Events in High-risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) Trials." Circulation (New York, N.Y.), vol. 121, no. 12, 2010, p. 1439, https://doi.org/10.1161/CIRCULATIONAHA.109.864199.